T&L Co., Ltd. (KOSDAQ:340570)
South Korea · Delayed Price · Currency is KRW 27,550
0.00 (0.00%)
Oct 2, 2026, 3:30 PM KST
T&L Co., Ltd. Market Cap
T&L Co., Ltd. has a market cap or net worth of 440.79 billion as of October 2, 2026. Its market cap has increased by 9.32% in one year.
Market Cap
440.79B
Enterprise Value
338.60B
Revenue
175.16B
Ranking
n/a
PE Ratio
8.71
Stock Price
27,550.00
ChartMarket Cap Chart
Since November 20, 2020, T&L Co., Ltd.'s market cap has increased from 219.46B to 440.79B, an increase of 100.86%. That is a compound annual growth rate of 12.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 440.79B | 11.33% |
| Dec 30, 2025 | 395.93B | -26.68% |
| Dec 30, 2024 | 540.02B | 67.25% |
| Dec 28, 2023 | 322.88B | 10.50% |
| Dec 29, 2022 | 292.21B | -23.99% |
| Dec 30, 2021 | 384.45B | 121.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SD Biosensor | 754.80B |
| InBody Co.,Ltd | 712.71B |
| i-SENS | 496.33B |
| BioNote | 473.79B |
| WON TECH | 441.16B |
| Samyang Biopharm | 365.84B |
| Curexo | 356.48B |
| Sky Labs | 350.85B |